Melinta Therapeutics
| Use attributes for filter ! | |
| Stock price | MLNTQ |
|---|---|
| Disclaimer | |
| Ceo | Dan Wechsler |
| Headquarters | New Haven |
| Connecticut | |
| United States | |
| Founders | Thomas A. Steitz |
| Founded | 2000 |
| Subsidiaries | Cempra Pharmaceuticals, Inc |
| Cem-102 Pharmaceuticals, Inc | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2476705 |
About Melinta Therapeutics
Melinta Therapeutics, founded in 2000 as Rib-X Pharmaceuticals, is an American publicly traded biopharmaceutical firm that focuses on the design and development of novel broad-spectrum antibiotics for the treatment of antibiotic-resistant infections in hospital and community settings.
